Compare TCMD & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TCMD | SOPH |
|---|---|---|
| Founded | 1995 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 514.9M | 462.3M |
| IPO Year | 2016 | 2021 |
| Metric | TCMD | SOPH |
|---|---|---|
| Price | $22.47 | $8.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $39.00 | $9.75 |
| AVG Volume (30 Days) | 226.4K | ★ 625.5K |
| Earning Date | 11-02-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.14 | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.97 | $23.24 |
| Revenue Next Year | $9.44 | $24.63 |
| P/E Ratio | $83.50 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.00 | $3.75 |
| 52 Week High | $37.77 | $8.98 |
| Indicator | TCMD | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 44.10 | 52.35 |
| Support Level | $21.29 | $7.71 |
| Resistance Level | $27.67 | $8.84 |
| Average True Range (ATR) | 0.61 | 0.42 |
| MACD | 0.11 | -0.04 |
| Stochastic Oscillator | 41.25 | 43.25 |
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.